Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION

(MCK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

MCKESSON CORP : Results of Operations and Financial Condition (form 8-K)

share with twitter share with LinkedIn share with facebook
05/20/2020 | 07:07am EDT
Item 2.02   Results of Operations and Financial Condition
On May 20, 2020, McKesson Corporation ("Company") announced via press release
the Company's preliminary results for the quarter ended on March 31, 2020. A
copy of the Company's press release is attached hereto as Exhibit 99.1.
The information contained in this Form 8-K, including Exhibit 99.1, is furnished
to the Securities and Exchange Commission (the "Commission"), but shall not be
deemed "filed" with the Commission for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act except as shall be expressly set forth by specific reference in
such a filing.
Item 9.01   Financial Statements and Exhibits.
(d) Exhibits.


Exhibit No.                                  Description

       99.1       Press release issued by the Company dated May 20, 2020
        104     Cover Page Interactive Data File - the cover page iXBRL tags are
                embedded within the Inline XBRL document



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
Latest news on MCKESSON CORPORATION
07/01MCKESSON : Changes Business-Unit Structure
DJ
07/01MCKESSON CORP : Regulation FD Disclosure, Financial Statements and Exhibits (for..
AQ
07/01MCKESSON : Realigns Organizational Structure to Better Serve Customers and Patie..
BU
06/30KARYOPHARM THERAPEUTICS : XPOVIO, FDA Approved for Treatment of Relapsed or Refr..
AQ
06/29MCKESSON : XPOVIO (selinexor), FDA Approved for Treatment of Relapsed or Refract..
PU
06/19MCKESSON : Partners with Walmart to Deliver nearly 10 million Critical Medical G..
PU
06/05MCKESSON : Appoints Tom Rodgers to Executive Vice President and Chief Strategy a..
AQ
06/04MCKESSON : Appoints Tom Rodgers to Executive Vice President & Chief Strategy and..
BU
06/03ELI LILLY AND : RETEVMO, FDA-Approved for Treatment of RET-driven Lung and Thyro..
AQ
06/02MCKESSON : RETEVMO (selpercatinib), FDA-Approved for Treatment of RET-driven Lun..
PU
More news